Sino Biological Completes Acquisition of SignalChem Biotech, Expanding Global Footprint and Product Offerings
Sino Biological, a leading biotechnology company specializing in biological research reagents and services, has successfully finalized its acquisition of SignalChem Biotech Inc., a renowned Canadian biotechnology company based in Vancouver. The acquisition, valued at $48 million USD, includes all assets of SignalChem Biotech and marks a significant step forward for Sino Biological in expanding its global presence and product portfolio. Acquisition Details Sino Biological, listed on the Shenzhen stock exchange subsidiary ChiNext, has acquired 100% of SignalChem Biotech’s shares in a strategic move to strengthen its position in the biotechnology market. SignalChem Biotech , known for its expertise in producing specialized bioactive enzymes such as kinases, proteases, and phosphatases, brings valuable assets and proprietary production platforms to the acquisition. With over two decades of experience, SignalChem Biotech has set industry standards for the development and production of...